Fligor, Scott C.
Tsikis, Savas T.
Hirsch, Thomas I.
Jain, Ashish
Sun, Liang
Rockowitz, Shira
Gura, Kathleen M.
Puder, Mark
Funding for this research was provided by:
National Institutes of Health (5T32HL007734, 2T32DK007754-22)
Beth Israel Deaconess Medical Center (Richard and Sandra Cummings Research Fellowship)
Boston Children's Hospital (Chairman’s Fellowship, Vascular Biology Program and Surgical Foundation)
NorthSea Therapeutics
Article History
Received: 26 July 2023
Accepted: 15 February 2024
First Online: 20 February 2024
Competing interests
: This study was funded in part by NorthSea Therapeutics under a sponsored research agreement (MP). MP and KG are paid external consultants to NorthSea Therapeutics. NorthSea Therapeutics was not involved in the collection, analysis, or interpretation of data presented in this manuscript. Additional support was received from National Institutes of Health grants 5T32HL007734 (SF, TH) and 2T32DK007754-22 (ST), the Beth Israel Deaconess Medical Center Richard and Sandra Cummings Research Fellowship (SF), the Chairman’s Fellowship of the Boston Children’s Hospital Department of Surgery (SF), the Boston Children’s Hospital Vascular Biology Program (MP), and Boston Children’s Hospital Surgical Foundation (MP). All other authors declare no other competing interests.